(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cost of revenue | ||||||||||
Gross profit | ||||||||||
Operating expense | -34.67%80.64K | -64.62%84.26K | -70.86%602.92K | -76.67%97.72K | -72.63%143.6K | -77.31%123.44K | -59.04%238.15K | 4.14%2.07M | -21.04%418.88K | -9.35%524.7K |
Selling and administrative expenses | -34.22%78.09K | -46.69%82.08K | -45.54%507.03K | -50.80%95.4K | -42.44%138.97K | -54.30%118.71K | -34.74%153.95K | -20.32%930.99K | -32.73%193.89K | -14.68%241.43K |
-Selling and marketing expense | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 84.80%76.46K | -65.94%3.41K | --19.36K |
-General and administrative expense | -34.22%78.09K | -46.69%82.08K | -40.67%507.03K | -49.92%95.4K | -37.42%138.97K | -54.30%118.71K | -22.22%153.95K | -24.18%854.53K | -31.53%190.49K | -21.52%222.07K |
Research and development costs | -46.11%2.55K | -97.41%2.18K | -91.57%95.88K | -98.97%2.32K | -98.37%4.62K | -98.33%4.73K | -75.63%84.2K | 39.06%1.14M | -7.13%224.99K | -4.25%283.27K |
Operating profit | 34.67%-80.64K | 64.62%-84.26K | 70.86%-602.92K | 76.67%-97.72K | 72.63%-143.6K | 77.31%-123.44K | 59.04%-238.15K | -4.14%-2.07M | 21.04%-418.88K | 9.35%-524.7K |
Net non-operating interest income (expenses) | -78.94%672 | -53.47%1.44K | 127.13%11.7K | -54.80%2.33K | 3.09K | 3.19K | 3.1K | 5.15K | 5.15K | 0 |
Non-operating interest income | ---- | -53.47%1.44K | 127.13%11.7K | -54.80%2.33K | --3.09K | ---- | --3.1K | --5.15K | --5.15K | --0 |
Total other finance cost | 78.94%-672 | ---- | ---- | ---- | ---- | ---3.19K | ---- | ---- | ---- | ---- |
Other net income (expenses) | 414.13K | |||||||||
Other non-operating income (expenses) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --414.13K | ---- | ---- |
Income before tax | 33.50%-79.97K | 64.77%-82.82K | 64.16%-591.21K | -24,128.72%-95.39K | 73.22%-140.51K | 77.89%-120.25K | 59.57%-235.06K | 16.97%-1.65M | 100.07%397 | 9.35%-524.7K |
Income tax | ||||||||||
Earnings from equity interest net of tax | ||||||||||
Net income | 33.50%-79.97K | 64.77%-82.82K | 64.16%-591.21K | -24,128.72%-95.39K | 73.22%-140.51K | 77.89%-120.25K | 59.57%-235.06K | 16.97%-1.65M | 100.07%397 | 9.35%-524.7K |
Net income continuous operations | 33.50%-79.97K | 64.77%-82.82K | 64.16%-591.21K | -24,128.72%-95.39K | 73.22%-140.51K | 77.89%-120.25K | 59.57%-235.06K | 16.97%-1.65M | 100.07%397 | 9.35%-524.7K |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 33.50%-79.97K | 64.77%-82.82K | 64.16%-591.21K | -24,128.72%-95.39K | 73.22%-140.51K | 77.89%-120.25K | 59.57%-235.06K | 16.97%-1.65M | 100.07%397 | 9.35%-524.7K |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 33.50%-79.97K | 64.77%-82.82K | 64.16%-591.21K | -24,128.72%-95.39K | 73.22%-140.51K | 77.89%-120.25K | 59.57%-235.06K | 16.97%-1.65M | 100.07%397 | 9.35%-524.7K |
Diluted earnings per share | 33.46%-0.0009 | 64.76%-0.0009 | 50.00%-0.01 | 0 | 84.63%-0.0015 | 86.85%-0.0013 | 74.29%-0.0026 | 0.00%-0.02 | 0 | 0.00%-0.01 |
Basic earnings per share | 33.46%-0.0009 | 64.76%-0.0009 | 50.00%-0.01 | 0 | 84.63%-0.0015 | 86.85%-0.0013 | 74.29%-0.0026 | 0.00%-0.02 | 0 | 0.00%-0.01 |
Dividend per share | ||||||||||
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.